DarioHealth (DRIO, Financial) has announced that its Chief Financial Officer, Zvi Ben-David, will be stepping down from his role, effective May 15. To ensure continuity, Ben-David will remain with the company until the end of June before transitioning to an advisory role.
Taking over the reins is Chen Franco-Yehuda, who has been appointed as the new CFO, Treasurer, and Secretary and will assume her duties on the same date. Franco-Yehuda brings a wealth of experience to DarioHealth, having previously held the same positions at Pluri, a prominent global biotech firm. Her accomplishments in the financial sector were recognized when she was honored with the Israeli CFO Excellence Award in January 2025.
Franco-Yehuda's career began in the field of audit and assurance at PwC, providing her with a solid foundation in financial management. As she steps into her new role at DarioHealth, the company anticipates a seamless transition in its financial leadership.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 3 analysts, the average target price for DarioHealth Corp (DRIO, Financial) is $2.67 with a high estimate of $5.00 and a low estimate of $1.00. The average target implies an upside of 255.56% from the current price of $0.75. More detailed estimate data can be found on the DarioHealth Corp (DRIO) Forecast page.
Based on the consensus recommendation from 3 brokerage firms, DarioHealth Corp's (DRIO, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for DarioHealth Corp (DRIO, Financial) in one year is $2.68, suggesting a upside of 257.33% from the current price of $0.75. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the DarioHealth Corp (DRIO) Summary page.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
